(Q54572327)

English

Are all KRAS mutations created equal?

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21782508

title

Are all KRAS mutations created equal? (English)

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21782508

author name string

Thomas E Stinchcombe

series ordinal

1

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21782508

Channing J Der

series ordinal

2

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21782508

publication date

22 July 2011

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21782508

published in

Lancet Oncology Commission

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21782508

volume

12

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21782508

issue

8

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21782508

page(s)

717-718

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21782508

cites work

Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970200-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970200-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970200-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970200-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Ras history: The saga continues

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970200-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970200-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S1470-2045(11)70200-5

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21782508

PubMed ID

21782508

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21782508

(Q54572327)

Are all KRAS mutations created equal?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)